65892 Federal Register / Vol. 77, No. 211 / Wednesday, October 31, 2012 / Notices 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: October 12, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–26596 Filed 10–30–12; 8:45 am] 

BILLING CODE M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 10 

(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ NATIONAL 

RESEARCH SERVICE AWARDS (NRSA) 

INSTITUTIONAL RESEARCH 

TRAINING GRANTS (T32)’’. 

DATES: November 14–15, 2012 (Open on 

November 14 from 8:00 a.m. to 8:30 a.m. 

and closed for the remainder of the 

meeting). 

ADDRESSES: Gaithersburg Marriott, RIO, 

9751 Washingtonian Boulevard, 

Gaithersburg, MD 20878. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. 

Individual members of the Panel do 

not attend regularly-scheduled meetings 

and do not serve for fixed terms or a 

long period of time. Rather, they are 

asked to participate in particular review 

meetings which require their type of 

expertise. 

Substantial segments of the SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

‘‘AHRQ NATIONAL RESEARCH 

SERVICE AWARDS (NRSA) 

INSTITUTIONAL RESEARCH 

TRAINING GRANTS (T32)’’ are to be 

reviewed and discussed at this meeting. 

The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Dated: October 12, 2012. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2012–26597 Filed 10–30–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Patient Safety Organizations: 

Voluntary Relinquishment From PDR 

Secure, LLC 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of Delisting. 

SUMMARY: The Patient Safety and 

Quality Improvement Act of 2005 

(Patient Safety Act), Public Law 109–41, 

42 U.S.C. 299b–21–b–26, provides for 

the formation of Patient Safety 

Organizations (PSOs), which collect, 

aggregate, and analyze confidential 

information regarding the quality and 

safety of health care delivery. The 

Patient Safety and Quality Improvement 

Final Rule (Patient Safety Rule), 42 CFR 

Part 3, authorizes AHRQ, on behalf of 

the Secretary of HHS, to list as a PSO 

an entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ by 

the Secretary if it is found no longer to 

meet the requirements of the Patient 

Safety Act and Patient Safety Rule, or 

when a PSO chooses to voluntarily 

relinquish its status as a PSO for any 

reason. AHRQ has accepted a 

notification of voluntary relinquishment 

from PDR Secure, LLC of its status as a 

PSO, and has delisted the PSO 

accordingly. 

DATES: The directories for both listed 

and delisted PSOs are ongoing and 

reviewed weekly by AHRQ. The 

delisting was effective at 12:00 Midnight 

ET (2400) on August 31, 2012. 

ADDRESSES: Both directories can be 

accessed electronically at the following 

HHS Web site: http:// 

www.pso.AHRQ.gov/index.html. 

FOR FURTHER INFORMATION CONTACT: 

Eileen Hogan, Center for Quality 

Improvement and Patient Safety, AHRQ, 

540 Gaither Road, Rockville, MD 20850; 

Telephone (toll free): (866) 403–3697; 

Telephone (local): (301) 427–1111; TTY 

(toll free): (866) 438–7231; TTY (local): 

(301) 427–1130; Email: 

pso@AHRQ.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The Patient Safety Act authorizes the 

listing of PSOs, which are entities or 

component organizations whose 

mission and primary activity is to 

conduct activities to improve patient 

safety and the quality of health care 

delivery. 

HHS issued the Patient Safety Rule to 

implement the Patient Safety Act. 

AHRQ administers the provisions of the 

Patient Safety Act and Patient Safety 

Rule (PDF file, 450 KB. PDF Help) 

relating to the listing and operation of 

PSOs. The Patient Safety Rule 

authorizes AHRQ to list as a PSO an 

entity that attests that it meets the 

statutory and regulatory requirements 

for listing. A PSO can be ‘‘delisted’’ if 

it is found no longer to meet the 

requirements of the Patient Safety Act 

and Patient Safety Rule, or when a PSO 

chooses to voluntarily relinquish its 

status as a PSO for any reason. Section 

3.108(d) of the Patient Safety Rule 

requires AHRQ to provide public notice 

when it removes an organization from 

the list of federally approved PSOs. 

AHRQ has accepted a notification 

from PDR Secure, LLC, PSO number 

P0098, which is a component entity of 

PDR Network, LLC, to voluntarily 

relinquish its status as a PSO. 

Accordingly, PDR Secure, LLC was 

delisted effective at 12:00 Midnight ET 

(2400) on August 31, 2012. PDR 

Network, LLC represents that it has 

patient safety work product (PSWP) in 

its possession. The PSO is obligated to 

meet the requirements of section 

3.108(c)(2)(i) of the Patient Safety Rule 

to notify the sources from which it 

received PSWP of the PSO’s intention to 

cease PSO operations and activities, to 

relinquish voluntarily its status as a 

PSO, to request that these other entities 


tkelley on DSK3SPTVN1PROD with NOTICES